Stay updated on M2951 in SLE Phase II Clinical Trial
Sign up to get notified when there's something new on the M2951 in SLE Phase II Clinical Trial page.

Latest updates to the M2951 in SLE Phase II Clinical Trial page
- Check2 days agoChange DetectedThe update shows a minor revision label changed from v3.4.0 to v3.4.1; no user-facing study content or functionality appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check3 days agoChange DetectedMinor site revision update from v3.4.0 to v3.4.1; no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoChange DetectedThese are minor UI and metadata updates: a 'Show glossary' option was added, capitalization tweaks were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page now displays 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe study documents revision was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check46 days agoChange DetectedLocations section expanded and reorganized to include new sites across the US and international locations (Argentina, Italy, Japan, Malaysia, Mexico, South Africa, etc.) with a new revision tag v3.3.3. The previous location listing has been updated to reflect the current trial sites.SummaryDifference2%

- Check75 days agoChange DetectedThe Publications section description was updated to indicate publications are automatically filled from PubMed, and the PubMed-related wording was revised; the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to M2951 in SLE Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M2951 in SLE Phase II Clinical Trial page.